Navigation Links
National Academy of Sciences honors geneticist and biologist Sue Biggins
Date:1/8/2013

SEATTLE Sue Biggins, Ph.D., a geneticist and biologist at Fred Hutchinson Cancer Research Center, has received the National Academy of Sciences Award in Molecular Biology. Sponsored by Pfizer Inc., the award consists of a $25,000 prize in recognition of a recent notable discovery by a young scientist.

She was among 18 honored by NAS this year for outstanding achievements in a wide range of fields spanning the physical, biological and social sciences.

Biggins, a member of the Fred Hutch Basic Sciences Division, was recognized for her work in understanding the mechanics of cell division. She recently made an important contribution to the field by figuring out how to isolate the specialized cellular machines known as kinetochores that allow cells to separate and accurately distribute their chromosomes.

For decades, researchers have tried and failed to isolate or assemble whole, functioning kinetochores to better understand how they help chromosomes separate and end up in the right daughter cells. If this goes awry, entire chromosomes are gained or lost, a hallmark of most cancers, birth defects and miscarriages.

Biggins' team, stepping away from genetic methods and borrowing from biochemists' playbook, for the first time succeed in separating the kinetochores from dividing yeast cells and studying them in test tubes.

During cell division, kinetochores act like handles on chromosomes and are under tremendous pressure as fibers pull on these handles to move the chromosomes within the dividing cell. If chromosomes fall off in the midst of this process, they don't end up in the daughter cell. Biggins and colleagues, in collaboration with the laboratory of Chip Asbury, Ph.D., in the Physiology and Biophysics Department at the University of Washington, found the harder the kinetochores are pulled, the harder they attach, like a finger-trap toy. This counterintuitive characteristic explains why the process works correctly so often.

What's true in yeast is also true in human cells. Because kinetochores play such an important role in chromosome segregation, knowing how they work turns them into very large therapeutic targets. If research leads to drugs that disrupt kinetochores from doing their job in unhealthy cells, they would be unable to divide and propagate at all, which potentially could stop a disease such as cancer.


'/>"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Related biology news :

1. International study suggests human genes influence gut microbial composition
2. January 2013 story tips from Oak Ridge National Laboratory
3. President Obama honors MU researcher with National Medal of Science
4. Spanish consumers prefer national fish
5. Barbara Gilchrest named 2012 Charter Fellow by National Academy of Inventors
6. National Academy of Inventors names four UT Arlington professors as charter fellows
7. LSUHSCs Weiss chosen to help set national eye policy, research
8. U of M to lead international virtual institute studying climatic and human effects on Earth
9. International Drug & Explosives Detection Company IDenta Corp. Article to be Published by Zillion International
10. Elk bones tell stories of life, death, and habitat use at Yellowstone National Park
11. National Geographic unveils new phase of genographic project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... With the biometrics market to exceed ... technologies that innovative and agile startups must incorporate ... the changing competitive landscape: multifactor authentication (MFA), point-of-sale ... "Companies can no longer afford to cut ... Dimitrios Pavlakis , Industry Analyst at ABI Research. ...
(Date:2/21/2017)... Ore. , Feb. 22, 2017  IBM (NYSE: ... (Avamere Health Services, Infinity Rehab, Signature Hospice, Home Health, ... will apply the power of IBM cognitive computing to ... centers. By analyzing data streaming from sensors in senior ... and environmental conditions, and obtain deeper learnings into the ...
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... 22, 2017 Scientists propose in Nature ... damage in Gaucher and maybe other lysosomal storage diseases ... costs than current therapies. An international research ... , which also included investigators from the University of ... data Feb. 22. The study was conducted in mouse ...
(Date:2/22/2017)... Dublin - Research and Markets has announced ... Type, By Application, By End User, By Region, By Country: Opportunities ... ... is forecasted to grow at a CAGR of 11.33% during 2016-2021. ... protection market is driven by the surging demand for less toxic ...
(Date:2/22/2017)... DIEGO , Feb. 22, 2017  Creative ... expansion of its translational research program using its ... of laboratory facilities in San Diego.  The Company ... BioLabs facility, a biotechnology incubator sponsored by the ... In November 2016, the Company obtained an ...
(Date:2/21/2017)... , ... February 21, 2017 , ... ... VTX-1 Liquid Biopsy System , a fully automated benchtop system for collecting intact ... VTX-1 is being launched at the Molecular Medicine Tri Conference (Tri-Con) Annual Meeting ...
Breaking Biology Technology: